Dr. Richard Moulange
speaker
1,784 appearances
1 recordings
1 series
first heard Mar 2026
last heard 31 Mar
Dr. Richard Moulange’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Mar 2026 with 1.
Appearances
So I think there are additional advantages by thinking about this particular area, because it is a chance for us to really cure human disease.
And so that's just another reason I think we should be excited and we need more work on the margin.
I'm not sure I agree that it's going to just be a delaying tactic.
I think there are ways that managed access could really be a win-win intervention.
And so when we think about managed access, we're thinking about two things.
We're thinking about denying access to malicious actors or to just people who have no need for that capability whatsoever.
The public does not fold proteins very often.
99% of the world does not in fact need the ability to modify viral proteins.
It's probably more like 99.9%.
Very few people actually work on influenza vaccines.
you could manage access and make it harder for them to access that capability without harming science, without harming the ability for us to research and discover new medicines.
But more than that, it's both things.
Managing access also means providing access to precisely those defenders who are doing good things.
This is going to be more and more important as we head to an agent-first bioinformatics ecosystem.
We are already seeing the LLMs now in agent scaffolds can use lots of different tools.
They can combine them together.
We're starting to get that inkling of you say something in natural language to complete this biological task.
It thinks what tools it needs.
It selects them in the right order.
It carries it through to completion.
Showing 741–760 of 1,784 · page 38 of 90
← Previous
Next →